Bright Minds Biosciences (DRUG) Research & Development (2019 - 2026)
Bright Minds Biosciences (DRUG) posted Research & Development of $6.69 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 244.3% from $1.94 million a year earlier but down 29.7% from the prior quarter.
Bright Minds Biosciences (DRUG) Research & Development (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Bright Minds Biosciences was $23.74 million, down 100.0% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $7.93 million, down 100.0% from FY2024.
- Annual Research & Development has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -87.5% (FY2020 to FY2025).
- In prior fiscal years, Bright Minds Biosciences' Research & Development was $867.55 billion in FY2024 (-76.6%), $3.71 trillion in FY2023 (-61.1%), $9.54 trillion in FY2022 (+91.0%) and $5 trillion in FY2021.
- Quarterly Research & Development has run from a low of -$414,373 in fiscal Q3 2024 to a high of $9.34 trillion in fiscal Q4 2022 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last three quarters, with growth averaging 154.3% over the last six quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was fiscal Q1 2026, with growth of 442.4%; the weakest was fiscal Q4 2025, with a decline of 100.0%.
- According to Business Quant data, Research & Development for the three prior fiscal quarters was $9.51 million (Q2 2026), $4.06 million (Q1 2026) and $3.48 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Bright Minds Biosciences | 379.80 Mn | 379.80 Mn | - | 6.69 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.69 Mn |
| Mar 31, 2026 | 9.51 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 3.48 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 748,325.78 |
| Sep 30, 2024 | 865.01 Bn |
| Jun 30, 2024 | -414,373.17 |
| Mar 31, 2024 | 78,055.47 |
| Dec 31, 2023 | 900,190.92 |
| Sep 30, 2023 | 3,729.61 Bn |
| Jun 30, 2023 | 782,185.04 |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 9,339.68 Bn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 2.96 Mn |
| Dec 31, 2021 | 3.05 Mn |
| Sep 30, 2021 | 5,015.89 Bn |
Bright Minds Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();